BiographySuresh Mahajan, PhD. of Pulsar Ventures Was Chief Medical Officer
and Vice President of R&D of Catalytica, Inc., a successful biotechnology
company that was sold in 2000 for $800 million; led development of catalytic
technology platform for the pharmaceutical industry that was led to
Catalytica’s growth from start-up to $400 million in revenue in 5 years;
over 30 years of experience in discovery and development of new technology
in the pharmaceutical and chemical industries; PhD. in chemical engineering
from Purdue University. |